Dihexa: Research dosing in animal models used 0.5 mg/kg
In a phase II trial, adults with a BMI of 30 or 27 kg/m with comorbidities were randomized to receive efpeglenatide at doses of 4 mg weekly, 6 mg weekly, 6 mg biweekly, or 8 mg biweekly, or a placebo, all combined with a hypocaloric diet [17]
The most common issues were nausea (20% to 47% depending on dose), followed by constipation, diarrhea, and abdominal discomfort
An aged hippocampus can improve its performance either by temporarily revving up acute repair mechanisms or by settling into a durable, low-growth, low-stress metabolic state
HA4919 Copper Peptide GHK-Cu Powder Enhance your skincare routine with Copper Peptide GHK-Cu